The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atorvastatin OPKO 40 mg film coated tablets



Opko Health Spain S.L.U.PA23271/001/001

Main Information

Trade NameAtorvastatin OPKO 40 mg film coated tablets
Active SubstancesAtorvastatin calcium trihydrate
Dosage FormFilm-coated tablet
Licence HolderOpko Health Spain S.L.U.
Licence NumberPA23271/001/001

Group Information

ATC CodeC10AA05 atorvastatin

Status

License statusAuthorised
Licence Issued09/06/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0001-004-003
Interchangeable List DocumentPDF of Interchangeable List
« Back